AU6780498A - Mycobacterium recombinant vaccines - Google Patents

Mycobacterium recombinant vaccines

Info

Publication number
AU6780498A
AU6780498A AU67804/98A AU6780498A AU6780498A AU 6780498 A AU6780498 A AU 6780498A AU 67804/98 A AU67804/98 A AU 67804/98A AU 6780498 A AU6780498 A AU 6780498A AU 6780498 A AU6780498 A AU 6780498A
Authority
AU
Australia
Prior art keywords
mycobacterium
coding region
animal
cells
selection marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67804/98A
Other languages
English (en)
Inventor
Abdel Hakim Labidi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exegenics Inc
Original Assignee
Cytoclonal Pharmaceutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytoclonal Pharmaceutics Inc filed Critical Cytoclonal Pharmaceutics Inc
Publication of AU6780498A publication Critical patent/AU6780498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU67804/98A 1997-03-28 1998-03-27 Mycobacterium recombinant vaccines Abandoned AU6780498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4284997P 1997-03-28 1997-03-28
US60042849 1997-03-28
PCT/US1998/006056 WO1998044096A2 (fr) 1997-03-28 1998-03-27 Vaccins recombines a base de mycobacteries

Publications (1)

Publication Number Publication Date
AU6780498A true AU6780498A (en) 1998-10-22

Family

ID=21924071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67804/98A Abandoned AU6780498A (en) 1997-03-28 1998-03-27 Mycobacterium recombinant vaccines

Country Status (6)

Country Link
EP (1) EP0973881A2 (fr)
JP (1) JP2001518781A (fr)
AU (1) AU6780498A (fr)
BR (1) BR9808441A (fr)
CA (1) CA2284736A1 (fr)
WO (1) WO1998044096A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1272213B1 (fr) * 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Systeme d'administration microbienne
US20040076639A1 (en) 2001-02-20 2004-04-22 Yasuhiro Yasutomi Novel medicinal use of alpha antigen or alpha antigen gene
WO2003006035A1 (fr) * 2001-07-10 2003-01-23 Stanford Rook Limited Compositions antivomitives
WO2013039069A1 (fr) 2011-09-13 2013-03-21 日本ビーシージー製造株式会社 Nouveau vaccin renfermant bcg recombinant
CN108285881B (zh) * 2018-01-04 2021-06-08 广州大学 一种具有同步产电和反硝化活性的分支杆菌及其应用
AU2019221709B2 (en) 2018-02-19 2024-04-18 Biofabri S.L. Compositions for use as a prophylactic agent to those at risk of infection of tuberculosis, or as secondary agents for treating infected tuberculosis patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807723A (en) * 1987-03-02 1998-09-15 Whitehead Institute For Biomedical Research Homologously recombinant slow growing mycobacteria and uses therefor
CA2045842A1 (fr) * 1990-07-16 1992-01-17 William R. Jacobs Adn capable de s'integrer dans un site particulier de mycobacteries
AU660430B2 (en) * 1990-11-08 1995-06-29 Stanford Rook Limited Mycobacterium as adjuvant for antigens
AU681572B2 (en) * 1991-10-21 1997-09-04 Med Immune, Inc. Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins

Also Published As

Publication number Publication date
CA2284736A1 (fr) 1998-10-08
BR9808441A (pt) 2000-05-23
EP0973881A2 (fr) 2000-01-26
WO1998044096A2 (fr) 1998-10-08
WO1998044096A3 (fr) 1999-01-14
JP2001518781A (ja) 2001-10-16

Similar Documents

Publication Publication Date Title
US7700104B2 (en) Attenuated Salmonella SP12 mutants as antigen carriers
EP1789559B1 (fr) Procédés de production de vaccins non antibiorésistants
AU2005312062B2 (en) Electroporation of Mycobacterium and overexpression of antigens in Mycobacteria
US7829104B2 (en) Electroporation of Mycobacterium and overexpression of antigens in mycobacteria
AU5356090A (en) Vaccines containing avirulent phop-type microorganisms
JP2000350578A (ja) 組み換えマイコバクテリアの発現ベヒクルおよびその使用
US6261568B1 (en) Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
WO2020096994A1 (fr) Adjuvants bactériens à autodestruction vivants pour améliorer l'induction de l'immunité
AU6780498A (en) Mycobacterium recombinant vaccines
MXPA99008868A (en) Mycobacterium recombinant vaccines
US20230165955A1 (en) Live self-destructing bacterial adjuvants to enhance induction of immunity
Mohamed et al. Protective Immunity to Listeria Monocytogenes Infection Mediated by
GICQUEL et al. Sommaire du brevet 2293826

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted